Forum Replies Created
I would be interested in a meetup in Southwest Ohio – Hamilton, Butler, Warren, Montgomery or Greene Counties.
Same experience here. Even the compounding pharmacy would not refill.
I’ve had a similar experience. Have no idea why the scratchy throat, but so far the rapid melt has always worked.
Ignore the conspiratorial title, Read the article, download the WHO document to verify
For a future week perhaps, as relevant to vaccine mandates.
Mild COVID induces long-lived memory plasma cells in the bone marrow. These are antibody producing cells that can respond to subsequent infections.
Research at WUSL think the immunity could be life-long…
Previous work focused on antibodies circulating in the blood stream. These go down with time. However, this may simply indicate that the need for surveillance is not acute. However, the presence of plasma cells in bone marrow shows that specific antibody producing cells are still there, hanging out, ready to mount a response when the need arises.
Here is the research paper
In addition, prior to these findings, WHO published a brief acknowledging that natural infection produces both the antibody response and T-cell response, the latter likely to be more robust against variants because it targets many parts of the virus.
So all in all, good news for those who have recovered from COVID.
The link in the previous post proposes a mechanism for vaccine associated blood clotting events.
From the start, I have been concerned that the COVID vaccines force our human cells to produce the viral spike protein, the “business end” of the virus. The spike protein has biological activity and is involved in COVID pathogenicity. It seems to be a risky antigen to use, given that our cells are being forced to express it.
Especially concerning fro this standpoint is that the JNJ and AZ vaccines introduce the genetic blueprint for spike protein in DNA form. Our human genetic blueprint is based on DNA (the SARS CoV-2 viral blueprint is based on RNA). Essentially, this means that the viral genetic blueprint in these particular vaccines is being introduced in the form of a human blueprint. Hypothetically, If the DNA inters the nucleus of the human cell, or perhaps even integrates into our own DNA, what if our cells now continue to produce this protein? What if the spike protein produced in this fashion enters the lymphatic system or the circulation? The spike protein produced could perhaps reach other organs beyond the site of inoculation via the bloodstream. This would place distant tissues at risk for effects caused by this “business end” of the virus, as seen in actual COVID infection. For me the risk has not been adequately characterized.
In the above research paper, the researchers show that with the DNA-based adenovirus vectors (the technology in JNJ and AZ vaccines), the synthetic genetic blueprint is read in the nucleus of our own cells, and is read in such a way that an unusual soluble spike protein can enter the bloodstream and interact with our tissues. At these distant sites, the binding of this protein can create an immune and inflammatory reaction in the blood vessels, which could be the mechanism for the unusual blood clotting events observed.
Such a mechanism is less likely with the RNA-based vaccines, as these are based on a modified RNA rather than a modified DNA blueprint. I’m not saying no side-effects would happen with RNA vaccines, as these also produce some form of spike protein (e.g., the CDC is investigating heart inflammation in young men). But one might expect side effects would differ in kind and/or probability.
The mass vaccination program with an experimental gene therapy is in fact a large-scale trial, IMHO. And shockingly, they are relying solely on an inadequate, adverse event reporting system to assess safety.
Now that an explanatory mechanism has been proposed for the blood clotting events being observed, the authorities ought to take immediate action.
Anyone following the experience in Israel? They have inoculated a substantial proportion of their population.
I’ve been very busy and incommunicado for a while, so just wondering. Has anyone on this site read the published clinical trials on the vaccines or the submissions made to the FDA to obtain the emergency use authorization? It is my understanding (second-hand information) that there was no difference between treatment and control groups in terms of the proportion of the subjects that became infected; that it was judged impractical to try to measure impact on transmission; and that the measure of “effectiveness” was reduced severity of symptoms. Is this the case? If these things are true, then the mass vaccination roll-out is the actual experiment to measure impact on infection and transmission, which would explain why we are still warned to wear masks and distance until we know better (but at the same time the carrot and stick approach is used to drive inoculation compliance.) If the studies have already been discussed on the site, would someone please direct me to the relevant threads. If not, I’ll look into this and report back in detail in a couple when my schedule eases up a bit. In the meantime, I’m doing my civic duty by remaining in the longer-term control group, because without one, there will be no way of deciphering whether any long-term effects are treatment-related or not. Besides, I know how to reduce severity of symptoms with early treatments that have established safety profiles.
One concern I have long had is the fact that these experimental gene therapy “vaccines” force our bodies to manufacture the spike protein. My concern is that the spike protein itself is biologically active. There is evidence of spike protein in pathological tissue of the heart, brain and other organ tissues in severe COVID, in the absence of complete viral particles, as far as understand it. The microthrombosis (minute blood clots) in severe COVID I believe was also linked to activity of the spike protein (don’t have a reference). That makes me wonder what happens if spike protein manufactured by our own cells in response to the vaccine could enter the blood stream and be responsible for unanticipated effects, like the clots with a backround of reduced platelet count seen in Oxford-AZ and JnJ DNA vaccines, or the prolonged heavy menstrual periods some women are experiencing after the vaccine.